European Case Law Identifier: | ECLI:EP:BA:2012:T167608.20120309 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 09 March 2012 | ||||||||
Case number: | T 1676/08 | ||||||||
Petition for review: | R 0008/13 | ||||||||
Application number: | 96102992.3 | ||||||||
IPC class: | A61K 31/485 A61K 9/20 A61P 25/04 |
||||||||
Language of proceedings: | EN | ||||||||
Distribution: | C | ||||||||
Download and more information: |
|
||||||||
Title of application: | Controlled release oxycodone compositions | ||||||||
Applicant name: | The Purdue Pharma Company Mundipharma GmbH Napp Pharmaceutical Holdings Limited Norpharma A/S Mundipharma Pharmaceuticals S.R.L. Mundipharma Laboratories GmbH Mundipharma Pharmaceuticals BV Mundipharma AB Mundipharma AG Mundipharma Farmaceutica LDA Mundipharma Pharmaceuticals SL Mundipharma GesmbH Mundipharma CVA |
||||||||
Opponent name: | Lannacher Heilmittel Ges.m.b.H. | ||||||||
Board: | 3.3.02 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: | |||||||||
Keywords: | For a list of keywords and decisions cited, see the PDF document | ||||||||
Catchwords: |
- |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t081676eu1.html
Date retrieved: 17 May 2021